You are here

Article info

Article menu

Download PDFPDF

Poster Presentations
P84 Regular monitoring of anti-C1q antibodies can be of help to predict lupus nephritis (LN) exacerbations

Authors

  • Marta Calatroni Dept. of Biomedical Sciences, Humanitas University, Pieve Emanuele Milan, Italy Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy PubMed articlesGoogle scholar articles
  • Emanuele Conte Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy Dept. of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy PubMed articlesGoogle scholar articles
  • Federica Bello Dept. of Experimental and Clinical Medicine, University of Firenze, Florence, Italy Internal Interdisciplinary Medicine Unit, Careggi University Hospital, Florence, Italy PubMed articlesGoogle scholar articles
  • Matteo Stella Dept. of Biomedical Sciences, Humanitas University, Pieve Emanuele Milan, Italy Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy PubMed articlesGoogle scholar articles
  • Francesco Reggiani Dept. of Biomedical Sciences, Humanitas University, Pieve Emanuele Milan, Italy Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy PubMed articlesGoogle scholar articles
  • Gabriella Moroni Dept. of Biomedical Sciences, Humanitas University, Pieve Emanuele Milan, Italy Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy PubMed articlesGoogle scholar articles

Citation

Calatroni M, Conte E, Bello F, et al
P84 Regular monitoring of anti-C1q antibodies can be of help to predict lupus nephritis (LN) exacerbations
Lupus Science & Medicine 2024;11:doi: 10.1136/lupus-2024-el.138

Publication history

  • First published March 14, 2024.
Online issue publication 
March 14, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ .